Table 4 of
Urbančič, Mol Vis 2020; 26:472-482. Table 4 of
Urbančič, Mol Vis 2020; 26:472-482.
Table 4. Paired comparison of vitreous and serum samples from patients with PDR – median (minimum-maximum); Wilcoxon signed rank test.
| Cytokine | patients with PDR (n=33) | ||
|---|---|---|---|
| vitreous | serum | P value | |
| MCP-1 (pg/ml) | 1614.98 (403.05–3990.74) | 72.6 (25.06–169.65) | 0.0001 |
| IL-8 (pg/ml) | 93.29 (20.04–295.71) | 11.99 (10.12–31.69) | 0.0001 |
| IL-6 (pg/ml) | 60.82 (13.64–798.23) | 5.46 (2.41–24.76) | 0.0001 |
| VEGF (pg/ml) | 304.64 (26.41–1439.3) | 38.66 (6.17–105.56) | 0.0001 |
| IL-1β (pg/ml) | 9.15 (7.51–67.36) | 7.6 (6.91–15.16) | 0.002 |
| TNF-α (pg/ml) | 13.41 (3.26–69.09) | 5.7 (2.9–23.35) | 0.005 |
| MIP-1α (pg/ml) | 9.55 (6.9–68.26) | 15.07 (7.78–91.74) | 0.002 |
| MIP-1β (pg/ml) | 12.09 (2.9–38.02) | 18.76 (6.89–48.83) | 0.009 |
| IL-10 (pg/ml) | 5.67 (4.9–8.12) | 7.4 (5.3–15.28) | 0.001 |
| IL-12 (pg/ml) | 3.17 (0.68–22.26) | 17.7 (2.49–42.91) | 0.0001 |